Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Radiation Injuries 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 4Radiotherapy, Intensity-Modulated 2Low-Level Light Therapy 2Chemotherapy, Adjuvant 2olaparib 1Sodium Chloride 1Respiratory Physiological Phenomena 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1Proton Therapy 1Poly A 1Oxygen 1Mometasone Furoate 1Mass Screening 1Lymph Node Excision 1Lovastatin 1Hyperbaric Oxygenation 1Gene Expression Profiling 1G(M1) Ganglioside 1Flow Cytometry 1Enzyme-Linked Immunosorbent Assay 1Diagnosis 1Centella asiatica extract 1Blood Specimen Collection 1Adenosine Diphosphate Ribose 1Adenosine Diphosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × Lovastatin × Breast × Clear all
NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡